Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01663155 · ClinicalTrials.gov registry record

Chest Imaging, Breath, and Biomarkers in a Screening Trial

A clinical trial, sponsored by The Cleveland Clinic.

Completed
Registry status
1,424
Enrollment target

NCT01663155: Completed study, sponsored by The Cleveland Clinic.

NCT01663155 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 1,424 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01663155 has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
1,424 participants
Enrollment target

Study Summary

The investigators would like to see if lung cancer screening with chest x-rays,computer aided detection (CAD)and a lose dose CT scan can detect lung cancer in early stages when it is more responsive to treatment. The investigators would also like to see if early detection will reduce the incidence of symptomatic advanced lung cancer compared to no screening in former and current smokers with or without a family history of lung cancer who are 40-75 years old.

Primary Outcome

The false positive rates of chest x-ray with CAD and chest CT will be compared. The analysis will be based on the study subjects from this prospective study who test positive with chest x-ray and/or CT and who are determined not to have lung cancer during the follow-up period.

Interventions

  • DEVICE chest x-ray with or without CAD, lose dose CT scan

Trial Details

FieldValue
Enrollment Target 1,424 participants
Start Date 2008-09
Est. Completion 2014-05
The Cleveland Clinic

688 total trials

What the finished NCT01663155 record still lists

NCT01663155 is an observational study that tracks outcomes without assigning an intervention. Its 1,424 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 1 intervention - of which chest x-ray with or without CAD, lose dose CT scan is the first listed.

NCT01663155 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01663155 about?

NCT01663155 is a clinical study titled "Chest Imaging, Breath, and Biomarkers in a Screening Trial". The investigators would like to see if lung cancer screening with chest x-rays,computer aided detection (CAD)and a lose dose CT scan can detect lung cancer in early stages when it is more responsive to treatment. The investigators would also like to see if early detection will reduce the incidence o...

What is the current status of trial NCT01663155?

This trial is currently completed. The enrollment target is 1,424 participants. The study started on 2008-09. Estimated completion is 2014-05.

What interventions are being tested in trial NCT01663155?

The interventions under investigation include: chest x-ray with or without CAD, lose dose CT scan (DEVICE).

Who is sponsoring clinical trial NCT01663155?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05890404 · 1,410 participants · NA

    SGM Evidenced-Based Mental Healthcare Implementation

  • NCT07042451 · 1,410 participants · NA

    An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support

  • NCT07222566 · 1,410 participants · Phase 3

    A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • NCT04754022 · 1,440 participants · NA

    Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01663155, the US trial registry maintained by the National Library of Medicine. NCT01663155 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.